Concepedia

Miroslav Homza

MH

Statistics

Publications

12

Citations

2K

H-Index

12

Active since

2016

Affiliations

Harvard University(Current)

Thrombosis Research Institute

McMaster University

Charles University

Technical University of Munich

Miroslav Homza is an author at Harvard University specializing in medicine, thrombosis, and infectious disease molecular testing.

ORCID

Publications per year

2016–2023

12

Publications

12

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 880 citations · Full text

, , +12

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al. · The Lancet · 2017 · 756 citations · Full text

, , +13

Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE

Jeffrey I. Weitz, Sylvia Haas, Walter Ageno et al. · Journal of Thrombosis and Thrombolysis · 2020 · 115 citations · Full text

, , +11

Contemporary Management of Severe Symptomatic Aortic Stenosis

M Eugène, Piotr Duchnowski, Bernard Prendergast et al. · Journal of the American College of Cardiology · 2021 · 53 citations · Full text

, , +14

Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients

Sylvia Haas, Walter Ageno, Jeffrey I. Weitz et al. · Journal of Thrombosis and Haemostasis · 2019 · 41 citations · Full text

, , +10

1–5 of 12